electroCore (NASDAQ:ECOR) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.07) by 14.29 percent. This is a 33.33 percent decrease over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $2.16 million which beat the analyst consensus estimate of $2.02 million by 6.78 percent. This is a 69.84 percent increase over sales of $1.27 million the same period last year.
Home Newsfeeds electroCore Q2 EPS $(0.08) Misses $(0.07) Estimate, Sales $2.16M Beat $2.02M Estimate
electroCore Q2 EPS $(0.08) Misses $(0.07) Estimate, Sales $2.16M Beat $2.02M Estimate
electroCore (NASDAQ:ECOR) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.07) by 14.29 percent. This is a 33.33 percent decrease over losses of $(0.06) per share from the
Related Posts
China’s Nuclear Weapons Lab Used American Computer Chips Despite Export Ban: Report
January 29, 6:40 PM
The state-run China Academy of Engineering Physics (CAEP), one of China’s top nuclear weapons research institutes, has purchased U.S. computer chips despite its placement on a U.S. export blacklist in 1997.
Stryve Foods, Inc. Secures $4.1M In Funding To Support Growth
April 21, 8:09 AM
Stryve Foods, Inc. ("Stryve" or "the Company") (NASDAQ:SNAX), an emerging healthy snack and eating platform disrupting traditional consumer packaged goods (CPG) categories, and a leader in the
JP Morgan Maintains Overweight on Elanco Animal Health, Lowers Price Target to $32
July 18, 8:37 AM
JP Morgan analyst Chris Schott maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and lowers the price target from $37 to $32.